By day 3, the ELF GSH was actually less than the first day at only 250 M
A notable new concern is dysesthesia, an altered skin sensation described as sensitivity, pain, or burning, which occurred in about 23% of participants on the higher dose
In clinical practice, physicians should be proactive in asking people with type 1 diabetes whether, and at which glucose level, they feel hypoglycaemia in order to identify IAH and adjust individual glucose targets to prevent the occurrence of Level 3 hypoglycaemia
Lower insulin requirements are also noted in real-world studies (50, 51)
Understanding Your Prescription and Dosage Once deemed eligible, you will receive a personalized treatment plan that outlines your specific dosage and administration schedule for sublingual tirzepatide